The eighth principle of data protection (see summary of the Data Protection Act) requires that personal data not be transmitted outside the European Economic Area (the Member States of the European Union, Iceland, Norway and Liechtenstein), unless the country or territory to which the data is to be transferred offers an adequate level of protection of personal data. One of the exceptions is if you have appropriate consent. It is therefore important that you have clearly stated in your information and consent sheet that the data may be sent outside the UK or the EEA. The transmission and use of data is generally only intended as a summary and not as a complete guide to the transmission or use of data, in general, by various important considerations, including those relating to the duke IRB rules, the Health Insurance Portability and Accountability Act of 1996 as amended (“HIPAA”), ethical considerations as to whether or not the transmission and/or use of the data is subject to contractual restrictions, and intellectual property issues. A researcher who wishes to transfer or use data should be prepared to discuss with CRO, among others: the purpose of the transmission; the identity of the transferee and the transferee; the nature of the data to be transmitted (data of human subjects? do they contain identifiers?); whether the data was collected as part of a research study or standard of treatment and, if there is a research study, whether restrictions may be imposed by third parties; whether an applicable declaration of consent allows the use or transmission of the proposed data; the way in which the data is transmitted; whether the patents are data-bound; and whether samples are sent with or in connection with the data. The transmission and use of personal data is a complex matter that cannot be adequately processed on this website. Duke researchers who wish to transfer or use human data should contact ORC to initiate a debate about the transmission or use of proposed data. The DTAS that researchers receive from external parties for detailed records must be verified by a member of the research office`s contract team before the data is transferred, as the conditions must be carefully compared to the current funding terms an agreement between organizations that regulates the transfer of one or more datasets from the owner/provider to a third party. This guide defines the clinical school procedures that govern the transmission, from and in depth, of data sets between the clinical school and a beneficiary organization. In order to atrophy confusion about what constitutes protected health information (“IHP”) (health information containing additional information that can be used to identify the data substitute) by HIPT, a researcher should understand that HIPAA identifiers define identifiers as one of the following definitions: in order to comply with information governance, it is necessary to put in place a data transfer agreement that allows Both the transfer of datasets between information services 100,000,000 0 Normally, we expect only anonymized data to be transferred A DBA must be set up by a member of the contract team at the research office before transmitting data Whenever it is possible to perform research on coded or fully anonymized data. In the event that identifiable information is requested from third parties or staff members, care should be taken to ensure that no obligation of confidentiality is breached. .